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Background
The accurate identification of HIV-1-specific T cell
responses is important for determining the relationship
between immune responses and viral control. Overlap-
ping peptides were synthesized to span gag and nef core
'mosaic' proteins. Mosaic proteins were assembled from
fragments of natural sequence using an optimized com-
putational biology method (W. Fischer et al., Nature Med-
icine, 2007). These proteins resemble natural proteins
and were designed to maximize the coverage of potential
T cell epitopes. Whilst recent studies have shown that
mosaic proteins are highly immunogenic in mice models
(W.P. Kong et al., J Virol, 2009), it remains unknown
whether mosaics when compared with consensus peptide
sets will detect a greater breadth of T cell responses in nat-
ural HIV-1 infection.
Methods
Twenty-six HIV-1 clade B infected antiretroviral therapy
naive individuals were included in the study. T cell
responses were assessed by an IFN-γ-ELISPOT assay using
overlapping consensus peptides that span the whole gag
and the conserved nef region base on clade B virus and
corresponding mosaic peptide sets.
Results
Initial studies in 26 patients demonstrated that mosaics
detected a greater breadth of responses than consensus
peptides in 16 subjects. In 7 subjects the same breadth of
responses was detected and in 3 subjects consensus pep-
tides detected more epitopes. Overall, T cells recognized
an average of 5 mosaic peptides (range, 1–12) and 3 con-
sensus peptides (range, 1–11) that was statistically signif-
icant (p < 0.0001, Wilcoxon signed-rank test using
GraphPad Prism software).
Conclusion
Studies suggest an increased coverage of T-cell epitopes
derived from natural infection by mosaic peptides. The
inclusion of mosaic peptides is recommended to improve
detection of HIV-1 specific T cells in natural infection.
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